XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.32

+1.4%

3:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (16823)	5/1/2004 2:54:42 PM
From: Bluegreen	of 17367

George, I would think that the Genentech sales reps would be CONSTANTLY reminding physicians of the side effects of ENBREL and their culpability in using ENBREL when they could of prescribed Raptiva. This is a NO BRAINER. The FIRST question asked of the Physician during discovery in an ENBREL lawsuit regarding treatment of Psoriasis.......Did you try any other therapies including Raptiva first????? ONCE AGAIN A NO BRAINER.......WHY USE A HEAVY DUTY ANTI TNF WHEN THE LIGHT TOUCH RAPTIVA WILL DO????? Remember before Raptiva the Physician and patient was limited by choice so the increased risk might be justified BUT now they have RAPTIVA at their disposal to try.....ONCE A WEEK LIGHT TOUCH RAPTIVA!!!!!!!!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next